Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks. 

RSS icon

Noteworthy FDA approvals of the week: Ceiling-mounted CT angiography, AI for brain-adjacent bleeds

Two companies serving medical imagers just had products cleared for marketing in the U.S.

AI cardiology Cleerly soft plaque assessments

Cardiology startup raises $192M for AI-powered imaging assessments

The company has now raised $248M in total to help develop, commercialize and market its FDA-cleared technology. 

Examples of new cardiac CT technologies at the 2022 SCCT meeting. Top left clockwise, realistic 3D rendering inside the heart, the GE Revolution Apex scanner, Cleerly's AI automated soft plaque assessment, and CT strain imaging from Medis. #SCCT #SCCT2022 #YesCCT #CTA #CCTA, new computed tomography technology

PHOTO GALLERY: Cardiac CT advances at SCCT 2022

View a variety of images from the 2022 Society of Cardiovascular Computed Tomography (SCCT) meeting in Las Vegas.

hand x-ray radiograph

A ‘powerful’ tool: Commercially available AI significantly outperforms radiologist reads for trauma imaging

The software was put to the test on nearly 5,000 trauma radiographs, assessing for the presence of fractures, dislocations, elbow effusions and focal bone lesions. In some cases, it outperformed radiologists by as many as 82 points. 

Ancora Heart AccuCinch Ventricular Restoration System heart failure FDA

Regulatory Roundup: FDA clears AI-powered Apple Watch competitor, grants breakthrough designation to new heart failure device

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

Thumbnail

FDA clears AI assessor of stricken dense brain tissue

An AI startup has received the FDA’s go-ahead to market a new tool within its existing platform that automatically diagnoses stroke and brain injury in hyperdense brain tissue imaged with unenhanced CT.

neuroblastoma prognosis

18F-FDG PET/CT radiomics nomogram provides detailed insight into neuroblastoma

Better risk stratification can improve clinical decision making and better outcomes, experts involved in the study explained in EJR.

Left, coronary CT angiography of a vessel showing plaque heavy calcium burden. Right, image showing color code of various types of plaque morphology showing the complexity of these lesions. The right image was processed using the FDA cleared, AI-enabled plaque assessment from Elucid.

Cardiac CT soft plaque assessment may offer paradigm shift for coronary disease screening

New artificial intelligence software that can evaluate coronary CT scans to automatically assess soft plaques were by far the biggest technology advance discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting. 

Displaying 1425 - 1432 of 2963
Design by Adaptive Theme